Henan Taloph Pharmaceutical Stock (600222) Key Financial Indicators

6.67 -0.19-2.77%

Not Open 11/29 15:00 CST

6.89High6.65Low373.12KlotVolume

Henan Taloph Pharmaceutical Stock Key Stats

According to the latest financial report of Henan Taloph Pharmaceutical Stock, the latest earnings per share (TTM) for the company is -0.03. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: CNY

Cumulative Quarterly

BVPS

Analyzing a company's fundamentals? Check out Henan Taloph Pharmaceutical Stock's latest financial report to see how much their book value per share (BVPS) is currently at 2.53.

Currency: CNY

Cumulative Quarterly

Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Henan Taloph Pharmaceutical Stock shows that the company's current ratio is 1.07, indicating healthy liquidity.

Cumulative Quarterly

Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Henan Taloph Pharmaceutical Stock, the quick ratio is 0.80, indicating that the company can meet its short-term debt obligations.

Cumulative Quarterly

ROE

Want to learn more about the financial health of Henan Taloph Pharmaceutical Stock? The latest ROE figure is -1.12%, indicating that the company has stable profitability.

Cumulative Quarterly

ROA

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Henan Taloph Pharmaceutical Stock, the total asset return on investment (ROA) is -0.56%.

Cumulative Quarterly

Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Henan Taloph Pharmaceutical Stock's latest financial report to see how their gross margin is doing - currently at 25.29%.

Cumulative Quarterly

Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Henan Taloph Pharmaceutical Stock, the net profit margin is -1.35%, which is a good sign for its profitability.

Cumulative Quarterly

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Paper Trade Start

Symbol

Direction

Buy

Sell

Types

LMT Order

Price

QTY

Amount

Buy

600222 Henan Taloph Pharmaceutical Stock

Henan Taloph Pharmaceutical Stock Key Stats

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow